That guy is a fruit cake. Nataliya that is. Joe is
Post# of 36537
(Total Views: 252)
Posted On: 03/17/2020 9:06:59 PM
That guy is a fruit cake. Nataliya that is. Joe is eccentric. Just kidding Joe.
"That is when I stopped talking with him. Don’t need to be insulted since I don’t think I ever talked “more bullshit” than Nataliya"
Anyway, the big thing for us is to do our part and get paid.
BTW, you guys know I am invested to a modest degree in CYDY. It is amazing how similar these two companies are. Both are OTC(I can pick 'em), both are headed by non scientist CEO's, both need funding to get to the finish line and both have cancer and virus tech. Anyway my point is, like Generex, CYDY is also working with a China partner on Covid19 treatment(not vaccine). Recently, they announced they working on deals with other countries like Taiwan, Italy etc. I would think Generex/NGIO is contemplating the same concept. The work for China, once complete can be sold off by country, geographical area or outright to big pharma company for royalties. This isn't just a China story. Granted each country has there own requirements for trials but if it works, it works. Safety won't be an issue.
"That is when I stopped talking with him. Don’t need to be insulted since I don’t think I ever talked “more bullshit” than Nataliya"
Anyway, the big thing for us is to do our part and get paid.
BTW, you guys know I am invested to a modest degree in CYDY. It is amazing how similar these two companies are. Both are OTC(I can pick 'em), both are headed by non scientist CEO's, both need funding to get to the finish line and both have cancer and virus tech. Anyway my point is, like Generex, CYDY is also working with a China partner on Covid19 treatment(not vaccine). Recently, they announced they working on deals with other countries like Taiwan, Italy etc. I would think Generex/NGIO is contemplating the same concept. The work for China, once complete can be sold off by country, geographical area or outright to big pharma company for royalties. This isn't just a China story. Granted each country has there own requirements for trials but if it works, it works. Safety won't be an issue.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼